Lexicon Pharmaceuticals LXRX Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation?
- Lexicon Pharmaceuticals (LXRX) reported cash provided by (used in) operating activity, including discontinued operation of -$14.73M in Q1 2026.
- How has Lexicon Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Lexicon Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation increased by 66.4% year-over-year, from -$43.78M to -$14.73M.
- What is the long-term trend for Lexicon Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation?
- Over 3 years (2021 to 2024), Lexicon Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation has grown at a 27.1% compound annual growth rate (CAGR), from -$87.02M to -$178.78M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.